However, Zhang et al. found that high expression of LIMD2 may enhance the progression of non–small cell lung carcinoma (NSCLC); in addition, the overexpression of LIMD2 was closely related to lymph node metastasis, distant metastasis, and advanced stage. This evidence concerns the gene LIMD2 and non-small cell lung carcinoma.